» Articles » PMID: 14993393

Non-nuclear Actions of Estrogen: New Targets for Prevention and Treatment of Cardiovascular Disease

Overview
Journal Mol Interv
Specialty Molecular Biology
Date 2004 Mar 3
PMID 14993393
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Gender-based differences in the incidence of hypertensive and coronary artery disease, the development of atherosclerosis, and myocardial remodeling after infarction are attributable to the indirect effect of estrogen on risk factor profiles, such as cholesterol levels, glucose metabolism, and insulin levels. More recent evidence, however, suggests that activated estrogen receptor (ER) mediates signaling cascades that culminate in direct protective effects such as vasodilation, inhibition of response to vessel injury, limiting myocardial injury after infarction, and attenuating cardiac hypertrophy. Although the ER is usually thought of as a ligand-dependent transcription factor, it can also rapidly mobilize signals at the plasma membrane and in the cytoplasm. Thus, a greater understanding of ER function and regulation may lead to the development of highly specific therapeutics that mediate the prevention and treatment of cardiovascular diseases.

Citing Articles

Tailoring Potential Natural Compounds for the Treatment of Luminal Breast Cancer.

da Silva F, Brandao D, Ferreira E, Siqueira R, Ferreira H, da Silva Filho A Pharmaceuticals (Basel). 2023; 16(10).

PMID: 37895937 PMC: 10610388. DOI: 10.3390/ph16101466.


Potential Mechanisms of Bisphenol A (BPA) Contributing to Human Disease.

Cimmino I, Fiory F, Perruolo G, Miele C, Beguinot F, Formisano P Int J Mol Sci. 2020; 21(16).

PMID: 32796699 PMC: 7460848. DOI: 10.3390/ijms21165761.


Regulation of estrogen receptor signaling in breast carcinogenesis and breast cancer therapy.

Zhou Z, Qiao J, Shetty A, Wu G, Huang Y, Davidson N Cell Mol Life Sci. 2014; 71(8):1549.

PMID: 25031550 PMC: 3962223. DOI: 10.1007/s00018-013-1376-3.


Exogenous hormonal regulation in breast cancer cells by phytoestrogens and endocrine disruptors.

Albini A, Rosano C, Angelini G, Amaro A, Esposito A, Maramotti S Curr Med Chem. 2013; 21(9):1129-45.

PMID: 24304271 PMC: 4153070.


Distribution and posttranslational modification of synaptic ERα in the adult female rat hippocampus.

Tabatadze N, Smejkalova T, Woolley C Endocrinology. 2012; 154(2):819-30.

PMID: 23183182 PMC: 3548183. DOI: 10.1210/en.2012-1870.


References
1.
Pappas T, Gametchu B, Watson C . Membrane estrogen receptors identified by multiple antibody labeling and impeded-ligand binding. FASEB J. 1995; 9(5):404-10. DOI: 10.1096/fasebj.9.5.7896011. View

2.
McHugh N, Cook S, Schairer J, Bidgoli M, Merrill G . Ischemia- and reperfusion-induced ventricular arrhythmias in dogs: effects of estrogen. Am J Physiol. 1995; 268(6 Pt 2):H2569-73. DOI: 10.1152/ajpheart.1995.268.6.H2569. View

3.
White R, Darkow D, LANG J . Estrogen relaxes coronary arteries by opening BKCa channels through a cGMP-dependent mechanism. Circ Res. 1995; 77(5):936-42. DOI: 10.1161/01.res.77.5.936. View

4.
Sullivan Jr T, Karas R, Aronovitz M, Faller G, Ziar J, Smith J . Estrogen inhibits the response-to-injury in a mouse carotid artery model. J Clin Invest. 1995; 96(5):2482-8. PMC: 185902. DOI: 10.1172/JCI118307. View

5.
Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H . Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science. 1995; 270(5241):1491-4. DOI: 10.1126/science.270.5241.1491. View